^
BIOMARKER:

TNFRSF8 positive

i
Other names: TNFRSF8, TNF Receptor Superfamily Member 8, Tumor Necrosis Factor Receptor Superfamily Member 8, Lymphocyte Activation Antigen CD30, CD30L Receptor, Ki-1 Antigen, D1S166E, CD30, Tumor Necrosis Factor Receptor Superfamily, Member 8, Cytokine Receptor CD30, CD30 Antigen, TNFRSF8, Ki-1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
TNFRSF8 positive
Hodgkin Lymphoma
CD30-targeted CAR-T immunotherapy
Sensitive
:
C3
SOHO 2022 - 6 days - (New C3)
TNFRSF8 positive
Hodgkin Lymphoma
brentuximab vedotin
Sensitive
:
A1
TNFRSF8 positive
Cutaneous T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
TNFRSF8 positive
Diffuse Large B Cell Lymphoma
brentuximab vedotin
Sensitive
:
A2
TNFRSF8 positive
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A2
TNFRSF8 positive
Non-Hodgkin’s Lymphoma
TT11
Sensitive
:
C2
TNFRSF8 positive
Lymphoma
AFM13
Sensitive
:
C2
TNFRSF8 positive
Hodgkin Lymphoma
AFM13
Sensitive
:
C2
TNFRSF8 positive
Hodgkin Lymphoma
TT11
Sensitive
:
C3
TNFRSF8 positive
Peripheral T-cell Lymphoma
BV-ICE
Sensitive
:
C3
TNFRSF8 positive
Lymphoma
T-lymphocyte cell therapy
Sensitive
:
D